These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 19146899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
    Betts MR, Gray CM, Cox JH, Ferrari G.
    Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [HIV/AIDS vaccines: heading for new vaccine approaches?].
    Girard MP.
    Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Progress towards an AIDS mucosal vaccine: an overview.
    Yuki Y, Nochi T, Kiyono H.
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
    [Abstract] [Full Text] [Related]

  • 7. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A.
    Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
    [Abstract] [Full Text] [Related]

  • 8. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL.
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [Abstract] [Full Text] [Related]

  • 9. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J, Ngai N, Stone GW, Yue FY, Ostrowski MA.
    Vaccine; 2009 Aug 13; 27(37):5077-84. PubMed ID: 19573639
    [Abstract] [Full Text] [Related]

  • 10. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.
    Pantaleo G, Koup RA.
    Nat Med; 2004 Aug 13; 10(8):806-10. PubMed ID: 15286782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently.
    Kashi VP, Jacob RA, Paul S, Nayak K, Satish B, Swaminathan S, Satish KS, Ranga U.
    Vaccine; 2009 Nov 12; 27(48):6739-47. PubMed ID: 19744585
    [Abstract] [Full Text] [Related]

  • 13. Species-specific CD1-restricted innate immunity for the development of HIV vaccine.
    Takahashi H.
    Vaccine; 2010 May 26; 28 Suppl 2():B3-7. PubMed ID: 20510740
    [Abstract] [Full Text] [Related]

  • 14. Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice.
    Turbant S, Martinon F, Moine G, Le Grand R, Léonetti M.
    Vaccine; 2009 Aug 27; 27(39):5349-56. PubMed ID: 19607953
    [Abstract] [Full Text] [Related]

  • 15. The potential role of fowlpox virus in rational vaccine design.
    Beukema EL, Brown MP, Hayball JD.
    Expert Rev Vaccines; 2006 Aug 27; 5(4):565-77. PubMed ID: 16989636
    [Abstract] [Full Text] [Related]

  • 16. Humoral immunity to HIV-1: neutralization and beyond.
    Huber M, Trkola A.
    J Intern Med; 2007 Jul 27; 262(1):5-25. PubMed ID: 17598812
    [Abstract] [Full Text] [Related]

  • 17. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM, Ahlers JD.
    Trends Immunol; 2008 Nov 27; 29(11):574-85. PubMed ID: 18838298
    [Abstract] [Full Text] [Related]

  • 18. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
    Masopust D.
    J Intern Med; 2009 Jan 27; 265(1):125-37. PubMed ID: 19093965
    [Abstract] [Full Text] [Related]

  • 19. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.
    Chung AW, Kumar MP, Arnold KB, Yu WH, Schoen MK, Dunphy LJ, Suscovich TJ, Frahm N, Linde C, Mahan AE, Hoffner M, Streeck H, Ackerman ME, McElrath MJ, Schuitemaker H, Pau MG, Baden LR, Kim JH, Michael NL, Barouch DH, Lauffenburger DA, Alter G.
    Cell; 2015 Nov 05; 163(4):988-98. PubMed ID: 26544943
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 vaccine clinical trials: the Brazilian experience.
    Ersching J, Pinto AR.
    Rev Med Virol; 2009 Sep 05; 19(5):301-11. PubMed ID: 19650156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.